Magle Chemoswed
  • Why invest
    • Reasons to invest
    • Financial goals
    • Business model
    • Growth strategy
    • Risk management
    • Patient impact
    • Sustainability
    • Impact
    • Knowledge Base
  • Press releases
  • Investors
    • Offer/Erbjudande/Amniotics
    • Analyst coverage
    • Reports & presentations
    • Financial reports
    • Investor contacts
    • Rights issue/Företrädesemission
    • Merger/Fusion/Amniotics
  • Corporate governance
    • Board of directors
    • Group management
    • Audit committee
    • General meetings
    • Articles of association
    • Auditor
  • Financial calendar
  • The share
  • Career
Meny
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Decline all cookies.
Manage cookie preferencesACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. You also have the option to opt-out of these cookies. For more information about the cookies we use, see our Privacy Policy & Cookie Policy.
SPARA OCH ACCEPTERA
Drivs med CookieYes Logo
Home
Home

Contact us.

+46 (0)76 164 33 12
ir@maglechemoswed.com

Magle Chemoswed AB

Agneslundsvägen 27
212 15 Malmö
Sweden

 

Magle Group and Logos are registered trademarks of Magle Group. | Privacy policy | Cookie policy

Subscribe.

Receive company data continuously to your inbox.

Check the category of messages you would like to subscribe to below.

Check the languages you would like to subscribe to.

To subscribe, please read and approve our data storage policy to comply with GDPR.

A real email address must be provided.
The GDPR policy must be accepted.
An email has been sent to confirm your subscription.